About Regor
Regor is a company based in Boston (United States) founded in 2018 was acquired by Roche in September 2024.. Regor has raised $90 million across 2 funding rounds from investors including Roche, Qilu Pharmaceutical Group and Lilly Asia Ventures. Regor offers products and services including GDC-4198, RGT-075, RGT-419B, and RGT-587. Regor operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter Boston, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Regor Therapeutics Group
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Regor
Regor offers a comprehensive portfolio of products and services, including GDC-4198, RGT-075, RGT-419B, and RGT-587. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Next-generation inhibitor for breast cancer treatment in clinical trials
Oral small molecule for obesity and type 2 diabetes management
CDK inhibitor for advanced breast cancer patients
Next-gen treatment for breast cancer in phase trials
Unlock access to complete
Unlock access to complete
Funding Insights of Regor
Regor has successfully raised a total of $90M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $90 million completed in February 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $90.0M
- First Round First Round
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2021 | Amount | Series B - Regor | Valuation | Lilly Asia Ventures | |
| Jun, 2018 | Amount | Seed - Regor | Valuation | Qilu Pharmaceutical Group |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Regor
Regor has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include Roche, Qilu Pharmaceutical Group and Lilly Asia Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Mid-market companies are targeted for investment by Loayal Valley Capital.
|
Founded Year | Domain | Location | |
|
TF Capital is engaged in biotech investment and strategic support.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Regor
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Regor
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Regor Comparisons
Competitors of Regor
Regor operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Regor
Frequently Asked Questions about Regor
When was Regor founded?
Regor was founded in 2018.
Where is Regor located?
Regor is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Is Regor a funded company?
Regor is a funded company, having raised a total of $90M across 2 funding rounds to date.
What does Regor do?
Regor was founded in 2018 in Boston, United States, within the biotechnology sector. Therapeutics targeting oncology, autoimmune, and metabolic diseases are developed. A multi-disciplinary computational platform is employed, integrating structural biology, biopharmaceutics, PKPD modeling, and bioinformatics. Drug discovery processes are supported from target identification and lead optimization through to clinical proof of concept, with operations based in the United States.
Who are the top competitors of Regor?
Regor's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
What products or services does Regor offer?
Regor offers GDC-4198, RGT-075, RGT-419B, and RGT-587.
Who are Regor's investors?
Regor has 7 investors. Key investors include Roche, Qilu Pharmaceutical Group, Lilly Asia Ventures, Loayal Valley Capital, and LanTing Capital.